Plant exosomes non-coding RNA-mediated anti-inflammatory mechanisms

植物外泌体非编码RNA介导的抗炎机制

基本信息

  • 批准号:
    9036506
  • 负责人:
  • 金额:
    $ 47.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-12-01 至 2020-11-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The overall goal of this proposal is to define the role of edible plant exosomal non-coding small RNA (nc-sRNA) in the prevention of gut inflammation using the dextran sulfate sodium (DSS) induced colitis and three other gut inflammatory related mouse models. Although evidence is supportive of the beneficial effects for most edible plants taken as part of the diet, the evidence that specific plant-based supplements are beneficial is controversial, and the underlying mechanisms are not clear. The challenge is to isolate and characterize the biological activities of the essential functional unit contained in specific naturl products to determine if and how it's cellular and molecular effects on the host can be used in a beneficial manner. Our recently published data (1-5) indicates that exosome-like nanoparticles (ELNs) present in a number of edible plants including grapefruit and ginger have anti-inflammatory properties. Mice fed grapefruit ELNs (FELNs) are protected against DSS induced mouse colitis. Up take of FELNs by intestinal macrophages inhibits the release of IL-1β and IL-6 and the induction of HO-1 and IL-10 expression. Our preliminary data further indicate that FELNs carry high levels of specific nc-sRNA that inhibit the induction of proinflammatory cytokines by targeting intestinal macrophages. The nc-sRNA is associated with inactivation of macrophage miR155. A specific FELN nc-sRNA complexed with naringin binds to miR155 and subsequently prevents miR155 binding to 3-UTRs of certain anti-inflammatory genes, thus inhibiting the induction of proinflammatory cytokines. We have also demonstrated that ginger ELN nc-sRNAs promotes the production of IL-10 in lamina propria macrophages under steady-state as well as inflammatory conditions. Therefore, we hypothesize that plant ELNs carrying the nc-sRNA bioactive complex are taken up by intestinal macrophages and subsequently bind to inflammatory microRNAs, resulting in inhibition of induction of chronic inflammation cytokines, thereby preventing chronic intestinal inflammation. Our hypothesis will be tested in vitro and in vivo to determine: (1) whether FELN taken up by intestinal macrophages leads to induction of tolerant dendritic cells (DCs) through nc-sRNA-155 mediated anti-inflammatory effects since DCs are critical for gut immune tolerance and homeostasis through cross-talk with intestinal macrophages; (2) the factors that regulate sorting of anti-inflammatory nc-sRNA-155 into macrophage exosomes; and (3) which ginger ELNs nc-sRNA(s) are required for induction of anti- inflammatory IL-10 expressed in macrophages. Demonstration of the ELNs complex targeting to gut inflammatory cells would be a significant step forward in the understanding of how the plant kingdom interacts with the mammalian species to regulate anti-inflammatory responses through ELNs. The data generated should provide a foundation for selecting specific ELNs from different types of plants for personalized complementary medicine for patients and determine whether oral administration of a customized exosome isolated from different plants will have a synergistic/additive effect on prevention or treatment of disease.
 描述(由适用提供):该提案的总体目标是定义可食用的植物外泌体非编码小RNA(NC-SRNA)在使用葡萄糖硫酸钠(DSS)诱导的结肠炎和其他三种其他肠炎性相关的小鼠模型中使用葡萄糖硫酸钠(DSS)预防肠道注射的作用。尽管支持大多数可食用植物作为饮食的一部分的有益效果的证据,但具有特定植物补充剂是有益的证据是有争议的,而且基本机制尚不清楚。面临的挑战是要隔离和表征特定自然产品中包含的基本功能单元的生物学活性,以确定它是否以及如何以有益的方式使用其对宿主的细胞和分子影响。我们最近发表的数据(1-5)表明,包括葡萄柚和姜在内的许多可食用植物中存在的外泌体样纳米颗粒(ELN)具有抗炎特性。饲喂葡萄柚ELN(FELNS)的小鼠受到DSS诱导的小鼠结肠炎的保护。肠道巨噬细胞对FELN进行抑制,抑制了IL-1β和IL-6的释放以及HO-1和IL-10表达的诱导。我们的初步数据进一步表明,FELNS具有高水平的特异性NC-SRNA,这些NC-SRNA通过靶向肠道巨噬细胞来抑制促炎细胞因子的诱导。 NC-SRNA与巨噬细胞miR155失活有关。与Naringin复合的特定FELN NC-SRNA与MiR155结合,随后防止MiR155与某些抗炎基因的3-UTR结合,从而抑制促炎细胞因子的诱导。我们还证明,生姜ELN NC-SRNA促进了在稳态和炎症条件下在层次巨噬细胞中促进IL-10的产生。因此,我们假设携带NC-SRNA生物活性复合物的植物ELS被肠道巨噬细胞所吸收,然后与炎症性microRNA结合,从而抑制慢性炎症细胞因子的诱导,从而防止慢性肠道炎症。我们的假设将在体外和体内进行测试,以确定:(1)FELN是否被肠道巨噬细胞占据,导致通过NC-SRNA-155介导的抗炎作用诱导耐受性树突状细胞(DCS),因为DC自DC通过DC通过肠道免疫耐受性和脑托管而与无肠道造成肠道造成的抗脑膜化至关重要。 (2)调节抗炎NC-SRNA-155中分选巨噬细胞外泌体的因素; (3)诱导巨噬细胞中表达的抗炎IL-10所必需的姜汁NC-SRNA(S)。靶向肠道炎性细胞的ELNS复合物的证明将是了解植物王国如何与哺乳动物物种相互作用以通过ELN调节抗炎反应的重要一步。生成的数据应为患者选择不同类型的植物中的特定植物的特定ELN提供基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

HUANG-GE ZHANG的其他基金

RA synovial fibroblast exosomes(RA-EXo) mediated bone erosion via AhR/TRAF2pathway
RA滑膜成纤维细胞外泌体(RA-EXo)通过AhR/TRAF2通路介导骨侵蚀
  • 批准号:
    10622327
    10622327
  • 财政年份:
    2022
  • 资助金额:
    $ 47.3万
    $ 47.3万
  • 项目类别:
BLR&D Research Career Scientist Award application
BLR
  • 批准号:
    9899084
    9899084
  • 财政年份:
    2018
  • 资助金额:
    $ 47.3万
    $ 47.3万
  • 项目类别:
BLR&D Research Career Scientist Award application
BLR
  • 批准号:
    10454206
    10454206
  • 财政年份:
    2018
  • 资助金额:
    $ 47.3万
    $ 47.3万
  • 项目类别:
BLR&D Research Career Scientist Award application
BLR
  • 批准号:
    10265394
    10265394
  • 财政年份:
    2018
  • 资助金额:
    $ 47.3万
    $ 47.3万
  • 项目类别:
Mechanisms underlying edible exosome-like nanoparticles for prevention of brain inflammation
可食用外泌体样纳米颗粒预防脑部炎症的机制
  • 批准号:
    10668525
    10668525
  • 财政年份:
    2015
  • 资助金额:
    $ 47.3万
    $ 47.3万
  • 项目类别:
Mechanisms underlying edible exosome-like nanoparticles for prevention of brain inflammation
可食用外泌体样纳米颗粒预防脑部炎症的机制
  • 批准号:
    10517568
    10517568
  • 财政年份:
    2015
  • 资助金额:
    $ 47.3万
    $ 47.3万
  • 项目类别:
Exosomal TRAF2-CSN5 complex mediated inflammation promotes tumor growth
外泌体TRAF2-CSN5复合物介导的炎症促进肿瘤生长
  • 批准号:
    8212755
    8212755
  • 财政年份:
    2011
  • 资助金额:
    $ 47.3万
    $ 47.3万
  • 项目类别:
Exosomal TRAF2-CSN5 complex mediated inflammation promotes tumor growth
外泌体TRAF2-CSN5复合物介导的炎症促进肿瘤生长
  • 批准号:
    8696800
    8696800
  • 财政年份:
    2011
  • 资助金额:
    $ 47.3万
    $ 47.3万
  • 项目类别:
Exosomal TRAF2-CSN5 complex mediated inflammation promotes tumor growth
外泌体TRAF2-CSN5复合物介导的炎症促进肿瘤生长
  • 批准号:
    8044373
    8044373
  • 财政年份:
    2011
  • 资助金额:
    $ 47.3万
    $ 47.3万
  • 项目类别:
Exosomal TRAF2-CSN5 complex mediated inflammation promotes tumor growth
外泌体TRAF2-CSN5复合物介导的炎症促进肿瘤生长
  • 批准号:
    8398935
    8398935
  • 财政年份:
    2011
  • 资助金额:
    $ 47.3万
    $ 47.3万
  • 项目类别:

相似国自然基金

多孔Ti-MSNs@MGF+DX抗炎—成肌体系应用于颞下颌关节假体的作用和机制研究
  • 批准号:
    82370984
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
基于仿生矿化法构建氢离子捕获的炎症调节性水凝胶微球在卒中治疗中的研究
  • 批准号:
    82372120
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
“消炎良境”铂药纳米制剂增强免疫治疗转移性结直肠癌的研究
  • 批准号:
    82073398
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
面向水中非甾体类消炎药选择性吸附光催化分解的金属有机框架的设计与机理研究
  • 批准号:
    21906007
  • 批准年份:
    2019
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Impact of tissue resident memory T cells on the neuro-immune pathophysiology of anterior eye disease
组织驻留记忆 T 细胞对前眼疾病神经免疫病理生理学的影响
  • 批准号:
    10556857
    10556857
  • 财政年份:
    2023
  • 资助金额:
    $ 47.3万
    $ 47.3万
  • 项目类别:
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
  • 批准号:
    10696512
    10696512
  • 财政年份:
    2023
  • 资助金额:
    $ 47.3万
    $ 47.3万
  • 项目类别:
Cellular and Metabolic Dysfunction in Sepsis-Induced Immune Paralysis
脓毒症引起的免疫麻痹中的细胞和代谢功能障碍
  • 批准号:
    10724018
    10724018
  • 财政年份:
    2023
  • 资助金额:
    $ 47.3万
    $ 47.3万
  • 项目类别:
Immune Modulation During Acute Lyme Disease Infection as the Result of Aberrant Immunoglobulin Glycosylation
异常免疫球蛋白糖基化导致急性莱姆病感染期间的免疫调节
  • 批准号:
    10726417
    10726417
  • 财政年份:
    2023
  • 资助金额:
    $ 47.3万
    $ 47.3万
  • 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
  • 批准号:
    10660332
    10660332
  • 财政年份:
    2023
  • 资助金额:
    $ 47.3万
    $ 47.3万
  • 项目类别: